APP and Alzheimer disease: According to this hypothesis, abnormal metabolism of amyloid precursor protein (APP) leads to excessive Aβ accumulation, which serves as a critical trigger in AD pathogenesis by inducing neuronal damage and neuroinflammation (Selkoe, 2008).